| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000232336.1 |
Afatinib |
Head and neck squamous cell carcinoma |
0.004351798 |
Resistant |
| ENSG00000232336.1 |
Afatinib |
Kidney renal clear cell carcinoma |
0.033201631 |
Resistant |
| ENSG00000232336.1 |
Afatinib |
Stomach adenocarcinoma |
0.00988445 |
Resistant |
